Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.

Authors

Ayola A Adegnika
Sophia G de Vries
Frejus J Zinsou
Yabo J Honkepehedji
Jean-Claude Dejon Agobé
Kafui G Vodonou
Rodrigue Bikangui
Aurore Bouyoukou Hounkpatin
Emmanuel B Bache
Marguerite Massinga Loembe
Remko van Leeuwen
Marjan Molemans
Peter G Kremsner
Maria Yazdanbakhsh
Peter J Hotez
Maria Elena Bottazzi
Guangzhao Li
Jeffrey M. Bethony, George Washington University
David J. Diemert, George Washington University
Martin P Grobusch

Document Type

Journal Article

Publication Date

2-1-2021

Journal

The Lancet Infectious Diseases

Volume

21

Issue

2

Inclusive Pages

275-285

DOI

10.1016/S1473-3099(20)30288-7

Comments

Epub 2020 Sep 11

APA Citation

Adegnika, A., de Vries, S., Zinsou, F., Honkepehedji, Y., Dejon Agobé, J., Vodonou, K., Bikangui, R., Bouyoukou Hounkpatin, A., Bache, E., Massinga Loembe, M., van Leeuwen, R., Molemans, M., Kremsner, P., Yazdanbakhsh, M., Hotez, P., Bottazzi, M., Li, G., Bethony, J. M., Diemert, D. J., & Grobusch, M. (2021). Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.. The Lancet Infectious Diseases, 21 (2). http://dx.doi.org/10.1016/S1473-3099(20)30288-7

Peer Reviewed

1